Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Applicants can choose from several submission methods: Online submission through the Manitoba Public Insurance website
Whether these rapid responses reflect true biological effects or placebo components remains difficult to distinguish
Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB, and Bulkey GB (1992)
Biochim Et Biophys Acta (BBA) - Mol Basis Disease
V9302, a competitive antagonist that targets transmembrane glutamine transport, blocks the glutamine transport process in tumor cells by efficiently and selectively binding to the glutamine transporter SLC1A5 [65]
US$ 25.52
US$ 27.89
US$ 27.72
US$ 23.53
US$ 24.94
US$ 29.88
US$ 23.37
US$ 29.51
US$ 27.51
US$ 27.77
